Kathryn B. Egan

1.2k total citations · 1 hit paper
18 papers, 803 citations indexed

About

Kathryn B. Egan is a scholar working on Health, Toxicology and Mutagenesis, Urology and Sociology and Political Science. According to data from OpenAlex, Kathryn B. Egan has authored 18 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Health, Toxicology and Mutagenesis, 5 papers in Urology and 4 papers in Sociology and Political Science. Recurrent topics in Kathryn B. Egan's work include Heavy Metal Exposure and Toxicity (7 papers), Urinary Bladder and Prostate Research (5 papers) and Environmental Justice and Health Disparities (4 papers). Kathryn B. Egan is often cited by papers focused on Heavy Metal Exposure and Toxicity (7 papers), Urinary Bladder and Prostate Research (5 papers) and Environmental Justice and Health Disparities (4 papers). Kathryn B. Egan collaborates with scholars based in United States, Norway and Australia. Kathryn B. Egan's co-authors include Adrienne S. Ettinger, Michael B. Bracken, Joseph G. Courtney, Mary Jean Brown, David M. Homa, Andrew T. DeWan, C.A. Marsden, David G. Wong, Kyle M. Walsh and Karen Hellenbrand and has published in prestigious journals such as Environmental Science & Technology, American Journal of Public Health and Environmental Health Perspectives.

In The Last Decade

Kathryn B. Egan

17 papers receiving 786 citations

Hit Papers

The Epidemiology of Benign Prostatic Hyperplasia Associat... 2016 2026 2019 2022 2016 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn B. Egan United States 11 327 295 168 165 132 18 803
Bülent Alıcı Türkiye 16 119 0.4× 87 0.3× 146 0.9× 54 0.3× 21 0.2× 32 829
R. Toro Italy 18 150 0.5× 192 0.7× 125 0.7× 24 0.1× 122 0.9× 36 825
Tong-Zu Liu China 16 125 0.4× 323 1.1× 14 0.1× 90 0.5× 74 0.6× 40 947
Hamdi Özkara Türkiye 11 93 0.3× 45 0.2× 101 0.6× 42 0.3× 27 0.2× 39 537
MJ Stampfer United States 10 23 0.1× 295 1.0× 90 0.5× 32 0.2× 374 2.8× 12 1.5k
Ahmet Gökçe Türkiye 19 245 0.7× 81 0.3× 12 0.1× 64 0.4× 20 0.2× 66 909
Susanne Backman Nøhr Denmark 16 71 0.2× 45 0.2× 107 0.6× 102 0.6× 26 0.2× 28 970
Jeanne V. Zborowski United States 18 19 0.1× 29 0.1× 99 0.6× 35 0.2× 45 0.3× 32 1.5k
Alejandro Martínez‐Aguayo Chile 19 28 0.1× 102 0.3× 22 0.1× 21 0.1× 61 0.5× 82 1.1k
Giovanni Corona Italy 17 992 3.0× 536 1.8× 15 0.1× 357 2.2× 38 0.3× 24 1.5k

Countries citing papers authored by Kathryn B. Egan

Since Specialization
Citations

This map shows the geographic impact of Kathryn B. Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn B. Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn B. Egan more than expected).

Fields of papers citing papers by Kathryn B. Egan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn B. Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn B. Egan. The network helps show where Kathryn B. Egan may publish in the future.

Co-authorship network of co-authors of Kathryn B. Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn B. Egan. A scholar is included among the top collaborators of Kathryn B. Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn B. Egan. Kathryn B. Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zartarian, Valerie, Jianping Xue, Rogelio Tornero‐Velez, et al.. (2024). A U.S. Lead Exposure Hotspots Analysis. Environmental Science & Technology. 6 indexed citations
2.
Egan, Kathryn B., Timothy Dignam, Mary Jean Brown, Tesfaye Bayleyegn, & Curtis Blanton. (2022). Using Small Area Prevalence Survey Methods to Conduct Blood Lead Assessments among Children. International Journal of Environmental Research and Public Health. 19(10). 6151–6151. 3 indexed citations
3.
Zartarian, Valerie, et al.. (2022). Lead Data Mapping to Prioritize US Locations for Whole-of-Government Exposure Prevention Efforts: State of the Science, Federal Collaborations, and Remaining Challenges. American Journal of Public Health. 112(S7). S658–S669. 7 indexed citations
4.
Egan, Kathryn B., et al.. (2021). Blood Lead Levels in U.S. Children Ages 1–11 Years, 1976–2016. Environmental Health Perspectives. 129(3). 37003–37003. 106 indexed citations
5.
Courtney, Joseph G., et al.. (2021). Decreases in Young Children Who Received Blood Lead Level Testing During COVID-19 — 34 Jurisdictions, January–May 2020. MMWR Morbidity and Mortality Weekly Report. 70(5). 155–161. 21 indexed citations
6.
Ettinger, Adrienne S., Kathryn B. Egan, David M. Homa, & Mary Jean Brown. (2020). Blood Lead Levels in U.S. Women of Childbearing Age, 1976–2016. Environmental Health Perspectives. 128(1). 17012–17012. 44 indexed citations
7.
Egan, Kathryn B., Rebecca Tsai, & Stella O. Chuke. (2018). Integrating Childhood and Adult Blood Lead Surveillance to Improve Identification and Intervention Efforts. Journal of Public Health Management and Practice. 25(1). S98–S104. 5 indexed citations
8.
Egan, Kathryn B.. (2016). The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms. Urologic Clinics of North America. 43(3). 289–297. 351 indexed citations breakdown →
9.
Roehrborn, Claus G., Kathryn B. Egan, Martin Miner, et al.. (2016). Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia ( LUTS / BPH ) combined responders to tadalafil after 12 weeks of treatment. British Journal of Urology. 118(1). 153–160. 10 indexed citations
10.
Egan, Kathryn B., et al.. (2015). Perphenazine-Associated Hyperosmolar Hyperglycemic State. Journal of Clinical Psychopharmacology. 35(4). 485–486.
12.
Egan, Kathryn B., R. Rosen, Arthur L. Burnett, et al.. (2015). Rural vs. urban disparities in association with lower urinary tract symptoms and benign prostatic hyperplasia in ageing men, NHANES 2001-2008. International Journal of Clinical Practice. 69(11). 1316–1325. 17 indexed citations
13.
Egan, Kathryn B., Martin Miner, Kevin T. McVary, et al.. (2015). Do baseline estrogen and testosterone affect lower urinary tract symptoms (LUTS) prior to or after pharmacologic treatment with tadalafil?. Andrology. 3(6). 1165–1172. 1 indexed citations
14.
Egan, Kathryn B., Adrienne S. Ettinger, Andrew T. DeWan, et al.. (2014). General, but not abdominal, overweight increases odds of asthma among Norwegian adolescents: the Young‐HUNT study. Acta Paediatrica. 103(12). 1270–1276. 9 indexed citations
15.
Egan, Kathryn B., Adrienne S. Ettinger, Andrew T. DeWan, et al.. (2014). Longitudinal associations between asthma and general and abdominal weight status among Norwegian adolescents and young adults: the HUNT Study. Pediatric Obesity. 10(5). 345–352. 16 indexed citations
16.
Egan, Kathryn B., Adrienne S. Ettinger, & Michael B. Bracken. (2013). Childhood body mass index and subsequent physician-diagnosed asthma: a systematic review and meta-analysis of prospective cohort studies. BMC Pediatrics. 13(1). 121–121. 134 indexed citations
17.
DeWan, Andrew T., et al.. (2012). Whole-exome sequencing of a pedigree segregating asthma. BMC Medical Genetics. 13(1). 95–95. 33 indexed citations
18.
Egan, Kathryn B., et al.. (2000). Comparison of donepezil-, tacrine-, rivastigmine-and metrifonateinduced central and peripheral cholinergically mediated responses in the rat. Journal of Psychopharmacology. 14(3). 275–279. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026